>

>

MDR Technical Documentation: An Annex II and III Checklist

MDR Technical Documentation: An Annex II and III Checklist

MDR Technical Documentation: An Annex II and III Checklist

Technical Documentation

Obodux Team

Under the EU Medical Device Regulation (EU) 2017/745 (MDR), every manufacturer must draw up technical documentation that shows the device meets the general safety and performance requirements, and keep it up to date. Annex II sets out what that documentation must contain. Annex III covers the technical documentation on post-market surveillance. For most devices a notified body reviews it before CE marking, and competent authorities can ask for it at any time.

This checklist walks through Annex II and III section by section: what each part must contain, what reviewers look for, and the gaps that most often send a file back.

At a glance

  • Section 1, device description and specification: intended purpose, users, classification, variants, accessories and Basic UDI-DI

  • Section 2, information supplied by the manufacturer: labels and instructions for use

  • Section 3, design and manufacturing information: design stages, manufacturing processes and validation, sites and suppliers

  • Section 4, general safety and performance requirements: the Annex I checklist with evidence for every requirement

  • Section 5, benefit-risk analysis and risk management

  • Section 6, product verification and validation: test results, biocompatibility, software, clinical evaluation and PMCF

  • Annex III: the PMS plan, plus the PMS report (Class I) or PSUR (Class IIa and above)

Section 1: Device description and specification

  • Product or trade name, and a general description including intended purpose and intended users

  • The Basic UDI-DI

  • Intended patient population, medical conditions, indications, contra-indications and warnings

  • Principles of operation and mode of action

  • Risk class and the Annex VIII classification rule applied, with the reasoning

  • Any novel features

  • Accessories, other devices and other products it is intended to be used with

  • All variants and configurations

  • Key functional elements, raw materials and materials in contact with the body

  • Previous generations of the device, and similar devices on the EU and international markets

What reviewers look for: an intended purpose used consistently across the whole file, and classification reasoning that names the rule and explains why it applies.

Section 2: Information supplied by the manufacturer

  • Labels on the device and its packaging (single unit, sales packaging and transport packaging)

  • Instructions for use, in the languages accepted in the member states where the device will be sold

What reviewers look for: labels and instructions that match the intended purpose, warnings and residual risks stated elsewhere in the file.

Section 3: Design and manufacturing information

  • Information to understand the design stages of the device

  • Complete information on the manufacturing processes and their validation, including continuous monitoring and final product testing

  • All sites, including suppliers and subcontractors, where design and manufacturing take place

Section 4: General safety and performance requirements

The file must show how the device meets each requirement in Annex I. In practice this is a checklist that states, for every requirement:

  • Whether it applies, and why not if it does not

  • The method used to show conformity

  • The harmonised standards, common specifications or other solutions applied

  • Exactly where the evidence sits in the file

What reviewers look for: every requirement that applies is backed by a precise reference to a document, not just a standard number.

Section 5: Benefit-risk analysis and risk management

  • The benefit-risk analysis referred to in Annex I, sections 1 and 8

  • The solutions adopted and the results of the risk management referred to in Annex I, section 3

Risk management is usually carried out to EN ISO 14971. Reviewers expect risk controls to trace through to the safety requirements, the labelling and the verification evidence.

Section 6: Product verification and validation

  • Results and critical analyses of all verification and validation tests and studies: engineering, laboratory, simulated use, animal tests and published literature

  • Biocompatibility of all materials in direct or indirect contact with the body

  • Physical, chemical and microbiological characterisation

  • Electrical safety and electromagnetic compatibility

  • Software verification and validation

  • Stability and shelf life

  • Performance and safety

  • The clinical evaluation plan and report, under Article 61 and Annex XIV

  • The post-market clinical follow-up (PMCF) plan and evaluation report, or a justification of why PMCF is not applicable

  • Additional information for specific cases, such as devices with a medicinal substance, sterile devices or devices with a measuring function

Annex III: Post-market surveillance

  • The post-market surveillance plan under Article 84

  • For Class IIa, IIb and III devices, the periodic safety update report (PSUR) under Article 86

  • For Class I devices, the post-market surveillance report under Article 85

The PMS plan should show how you collect and use information on quality, performance and safety, how you report serious incidents and field safety corrective actions, and how findings feed back into the risk management, clinical evaluation and technical documentation.

Mistakes that get technical files sent back

  • An intended purpose that changes between the device description, labelling and clinical evaluation

  • Classification reasoning that is missing or names the wrong rule

  • A safety requirements checklist ticked "complies" with no traceable evidence

  • Risk management that does not link to the safety requirements or the instructions for use

  • A clinical evaluation that does not support every claim and indication

  • Out-of-date versions, or documents that contradict each other between sections

  • A PMS plan that exists but is not connected to the rest of the file

Team-NB, the association of European notified bodies, publishes a best practice guide on MDR technical documentation, now in its fourth version (April 2026). It is worth reading alongside this checklist.

Frequently asked questions

What is the difference between a technical file and technical documentation?

"Technical file" was the usual term under the old Medical Device Directive. The MDR uses "technical documentation", but the terms are often used interchangeably for the documentation required by Annex II and III.

How long must MDR technical documentation be kept?

At least 10 years after the last device covered by the EU declaration of conformity has been placed on the market, and at least 15 years for implantable devices (Article 10(8)).

Who can ask to see it?

Your notified body reviews it as part of conformity assessment, and competent authorities can request it at any time.

Is the EU declaration of conformity part of the technical documentation?

The declaration of conformity is a separate document, set out in Annex IV. It is usually kept with the technical documentation and must be consistent with it.

Do Class I devices need technical documentation?

Yes. Class I manufacturers draw up the same Annex II and III documentation, even though most Class I devices do not need a notified body.

Can one technical file cover both EU MDR and UKCA?

Much of the content can be shared, but the UK and EU have separate legal requirements and declarations, so check that each market's requirements and references are covered.

How Obodux helps

Obodux builds your technical documentation section by section against MDR Annex II and III. It links every safety requirement to its evidence and keeps versions and approvals in one place. It supports EU MDR and UKCA, so you can see the gaps before your notified body does. Get a free gap analysis or see our EU MDR technical file software.

Ready to structure your technical documentation?

Ready to structure your technical documentation?

Obodux is a SaaS platform that streamlines medical device compliance. Using AI tools and a secure workspace, it helps prepare CE, UKCA, and global documentation faster, stay audit-ready, and launch products confidently.

Compliance Disclaimer: Obodux provides tools to assist with regulatory compliance but does not guarantee regulatory approval. Users remain responsible for ensuring their compliance with applicable regulations.

Cyber Essentials Certified

© 2026 Obodux. All rights reserved. Obodux is the MedTech compliance product from BORIS Software Ltd.

Obodux, a product of BORIS Software Ltd
Turing House, 120 Millshaw, Beeston, Leeds LS11 8LZ, United Kingdom
Tel: 03300 414880

Obodux is a SaaS platform that streamlines medical device compliance. Using AI tools and a secure workspace, it helps prepare CE, UKCA, and global documentation faster, stay audit-ready, and launch products confidently.

Compliance Disclaimer: Obodux provides tools to assist with regulatory compliance but does not guarantee regulatory approval. Users remain responsible for ensuring their compliance with applicable regulations.

Cyber Essentials Certified

© 2026 Obodux. All rights reserved. Obodux is the MedTech compliance product from BORIS Software Ltd.

Obodux, a product of BORIS Software Ltd
Turing House, 120 Millshaw, Beeston, Leeds LS11 8LZ, United Kingdom
Tel: 03300 414880

Obodux is a SaaS platform that streamlines medical device compliance. Using AI tools and a secure workspace, it helps prepare CE, UKCA, and global documentation faster, stay audit-ready, and launch products confidently.

Compliance Disclaimer: Obodux provides tools to assist with regulatory compliance but does not guarantee regulatory approval. Users remain responsible for ensuring their compliance with applicable regulations.

Cyber Essentials Certified

© 2026 Obodux. All rights reserved. Obodux is the MedTech compliance product from BORIS Software Ltd.

Obodux, a product of BORIS Software Ltd
Turing House, 120 Millshaw, Beeston, Leeds LS11 8LZ, United Kingdom
Tel: 03300 414880